22 – 23 April 2026

Abstracts

Abstracts 2026

Abstracts Book Image

Abstract Presenters & Titles

ORAL PRESENTATIONS
First NameLast NamePaper TitleType
DAY ONE   
AlexAdams‘Asthma 48’: implementation of telephone follow-up and triage post discharge after an acute exacerbation of asthma.Oral
Mali GeorginaDaviesPhase 3, Randomized, Controlled Trial Evaluating Safety, Efficacy, and Pharmacokinetics (PK) of Clesrovimab in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) DiseaseOral
EmmaGuyAsthma and Housing – Positive progress to improve the environmental health of CYP with asthma by the creation of a risk stratification tool and referral pathwayOral
RahulSharmaNovel Outpatient Non-Invasive Ventilation (NIV) Initiation Pathway: 7 Years of Experience at a regional specialist paediatric centreOral
JonathanSmithImaging lung structure and function in young children with PBB using 1H and 129Xe MRIOral
AlisonSummerfieldWorking collaboratively with educational colleagues to proactively
identify children and young people with sub-optimally controlled asthma,
optimise their care and reduce school absence.
Oral
SaraWarraichModified Hypoxic Challenge Testing for Children on Long Term Nocturnal VentilationOral
ThomasWilkinsonInvestigating Variations and Five-Week Temporal Changes in Oxygen Saturation Indices Between Late Preterm and Term Infants: A Cohort StudyOral
DAY TWO   
HarryApperleyClean Air, Healthy Futures: Utilising young people’s voices to guide clinical conversations and advocacy.Oral
DamilolaOladeleService evaluation of a ten-year cardiorespiratory polygraphy screening programme of children diagnosed with Prader-Willi syndrome on growth hormone at Southampton Children’s Hospital.Oral
DhandayuthapaniRajkumarHealth benefits of long-term respiratory support in  children and young people with cerebral palsy: More than just making the sleep study better….Oral
HannahVennardRole of overnight oximetry in assessing the severity of obstructive sleep apnoea in children with Down syndrome: a dual-centre studyOral
    
POSTER PRESENTATIONS 
First NameLast NamePaper TitleType
DAY ONE   
ChloeAllenEosinophilic granulomatosis with polyangitis (EGPA) in an adolescent – successful remission with BenralizumabPoster
JuiAndhariaLongitudinal trends in spirometry for children and young people with non-cystic fibrosis bronchiectasis managed at a regional Paediatric bronchiectasis servicePoster
SumanBhattacharyyaQuality Improvement project looking at completion of Emergency and Advanced Care plan discussion in patients on Long Term VentilationPoster
RheaClubbEvaluating the psychological wellbeing of children and young people seen in a tertiary asthma service.Poster
ChukwudumebiDuruDelivering and Evolving an Innovative Training Programme in PRM – The Sheffield Children’s Advanced Respiratory Training (SCART) ExperiencePoster
ReubenGibbonsChronic cough in a teenage: a presentation of Eosinophilic granulomatosis with polyangiitisPoster
EmanHassaninA Paediatric Case of Mycoplasma pneumoniae complicated by cold agglutinins-induced haemolysis and extensive thrombosisPoster
SadhbhHurleyOptimising Preschool Wheeze and Asthma Management: A Checklist based auditPoster
KathrynKimberTears, tantrums and terrors: Sleep disturbance and behavioural side effects in children aged 2-5 years with cystic fibrosis commencing triple CFTR modulator therapy, and a pathway for their management.Poster
RachelKnightlozanoExperiences of Monitoring Chest Health in Children with Complex Cerebral Palsy: Challenges and InsightsPoster
GargiNahaThe intersectionality of sex and deprivation on children and young people’s experience of emergency acute asthma care in high-income countries: rapid reviewPoster
UrvashiNandaSocioeconomic and ethnic predictors of fungal sensitisation in a paediatric difficult-to-treat asthma cohortPoster
JessicaRussellFeasibility and acceptability testing of a toolkit of interventions to help children and young people use non-invasive ventilation for sleep-disordered breathingPoster
AnkurSharmaGap Analysis of Paediatric TB Service Provision in the East of EnglandPoster
AnkurSharmaChanging Landscape of Research About The Use of E-Cigarettes in Children In the UKPoster
JonathanTwynam-PerkinsCFTR Genetics – when are CF mutations just not enough?Poster
BiancaVan BinsbergenThe utility of chest ultrasound in the detection of lung necrosis in children with complicated community-acquired pneumoniaPoster
GemmaWilsonRisk Factors Associated with Adverse Outcomes in Empyema in Children: A 5.5-Year Experience in a Tertiary CentrePoster
ShaunWilsonA cost effective, self-sustaining, and effective way of improving asthma understanding in undergraduate students.Poster
NaomiWinfieldGasping for attention: raising the standards for children with neurodisabilityPoster
DAY TWO   
SumanBhattacharyyaExperience with one child with a rare de-novo mutation of FOXF1 leading to a rare diffuse lung disease with misalignment of pulmonary veins.Poster
IdanBokobzaTowards consensus guidelines: an international survey of follow-up practices for babies exposed to CFTR modulators in utero and/or via lactationPoster
GeraldineBoyleQuality Improvement Project: Does Play Therapy Have a role in LRTI management in Children?Poster
Mali GeorginaDaviesA Phase 2b/3 Study to Evaluate the Efficacy and Safety of an Investigational Respiratory Syncytial Virus (RSV) Antibody, Clesrovimab, in Healthy Preterm and Full-Term InfantsPoster
EmanHassaninHeated, humidified high flow therapy at home setting in children with respiratory failure- Single centre experiencePoster
KathrynKimberMacrolide prophylaxis in recurrent paediatric chest infections: A low risk for resistance?Poster
RachelKnightlozanoCHESTI-Study: Core outcome set and measures of chest health in children and young people with cerebral palsy in the community settingPoster
MartinaLarssonRecognising an older chILD: A case presentation of idiopathic lymphocytic interstitial pneumonitisPoster
RebeccaLeckonbyAudit of Respiratory Virus Testing in Children at York HospitalPoster
MelvinLee QiyuImpact of food allergy on asthma outcomes of children from ethnic groups with difficult to treat asthma (DA)Poster
AnneMcgoughBursting for a DiagnosisPoster
UrvashiNandaSocioeconomic and ethnic predictors of fungal sensitisation in a paediatric difficult-to-treat asthma cohortPoster
DavidO’keeffeIncidence of Neonatal Pneumothoraxes in a Level Two Neonatal Unit Over The Past Decade: A Rising Concern?Poster
JennyO’NeillEarly improvement in Gastro-Intestinal symptoms in 2-5 year old children following the introduction of Elexacaftor/ Tezacaftor/ Ivacaftor (ETI)Poster
SenaliSeneviratneOscillometry for the Diagnosis of Asthma in Children: a Systematic ReviewPoster
AnkurSharmaImproving Clinician Knowledge and Practice on VapingPoster
JonathanSmithTransport and imaging of the Neonatal Lung using a whole-body MRI scanner and comparison with CT imagingPoster
RajeshSrikantaiahCongenital Tuberculosis: Case series and Literature
Review.
Poster
AlisonSummerfieldTitle: Childhood asthma online workshops: Empowering parents and care givers – an evaluation.Poster
AlisonSummerfieldA pilot study to determine the use of a structured 48-hour asthma review tool which can be used efficiently and effectively in clinical practice.Poster

 

Abstract Submission

The committee welcome the submission of original contributions for abstracts at the 12th KJP Paediatric Respiratory Conference 2026. We will be returning to paper posters for the conference, and in-person attendance will be required if presenting a poster.

As the excitement builds for the upcoming 12th KJP Paediatric Respiratory Conference, we want to draw your attention to a new opportunity to contribute – we are announcing two new abstract categories that are open for submissions: Challenging Cases in Respiratory and Challenging Cases in CF. More information about these new categories is given below.

Submission:
Abstracts can only be submitted through the online platform.

 

 Abstract Categories:

 

  • Asthma / Allergy
  • Cystic Fibrosis / Suppurative lung disease
  • Infection
  • Neonatal pulmonology / Congenital malformation
  • Physiology / Sleep / Non-Invasive Ventilation
  • Public Health / Environmental Health / Sustainable Healthcare
  • Challenging Cases in Respiratory Medicine
  • Challenging Cases in Cystic Fibrosis
  • QI Project

Information to assist with submitting your abstract

  • All accepted poster & oral presenters are required to register to attend in person for the KJP Paediatric Respiratory Conference.
  • Abstracts that are not accepted will be offered a full refund.
  • All accepted abstracts will be displayed in the poster gallery.
  • Selected abstracts will be included in an in-person oral presentation session.
  • Additional details on poster requirements and the oral presentation sessions will be included in the acceptance notification.
  • Abstracts should be no more than 350 words with one table or figure.
  • Please identify the abstract category that best fits your submission.
  • Any abstract uploaded after the advertised submission deadline will automatically be rejected.
  • Encore abstracts may be submitted provided they have only been presented at only one meeting previously, e.g. ERS or ATS. The author should send an e-mail to info@paediatricrespiratory.com detailing when and where their abstract had been previously presented.
  • Declarations of Interest: If there are specific issues related to conflicts of interest that the authors wish to declare in connection with a particular abstract, please send an email outlining the details to info@paediatricrespiratory.com and we will retain this information on file with your abstract.
  • Confirmation of abstract submission: Upon submission, a confirmation email will be sent to the submitters email address. If you do not receive the confirmation e-mail, please do not submit the abstract again. Instead, please contact info@paediatricrespiratory.com for advice.
  • Notification of acceptance: Notifications of acceptance or rejection of the abstracts will be sent to the presenting author of the abstract. All further communication, including notification letter, will be ONLY with the presenting author that has been indicated during the abstract submission.

Why write an abstract?

One of the key aims of the KJP Paediatric Respiratory Conference 2026 is to facilitate the development and dissemination of UK respiratory research. Writing an abstract affords an excellent opportunity to generate interest in your research and communicate findings to the UK respiratory research community. An abstract can be presented as a summary for your paper-in progress, providing a first opportunity to present preliminary research findings, communicate data and seek feedback on your work. It should be setting the foundation for publication in a peer reviewed journal.

Abstract Selection

Not all submitted abstracts can be selected for presentation and as such, a rigorous selection process is in place. Abstracts are reviewed by three or more expert reviewers.

Getting your abstract accepted

The following tips are provided to try and help you ensure that your abstract is successful in being accepted for the KJP Paediatric Respiratory Conference.

  • Research not Audit. With very few exceptions (e.g. large multi-centre audits with implications for service delivery) abstracts describing the results of audits will not be accepted for the conference. This is similar for case reports that are submitted.
  • Less is more. Avoid dividing your research into multiple abstracts. Your chances of abstract acceptance will be greatly enhanced by submitting a single abstract containing data from your research project rather than multiple abstracts detailing individual facets of your work.
  • Novelty. Abstracts presenting novel data and ideas usually score much more highly than those that replicate previous work. When presenting your research, emphasis should be placed on the novel aspects of your work and highlighting how this adds to current knowledge. Abstract reviewers are expert in their area and will have a good knowledge of the existing literature.
  • Give yourself time. Having done the hard work of doing the research, give yourself plenty of time to write the abstract. Do not underestimate the challenge of trying to present months, or even years of work in 350 words. A well-written, concise abstract ensures that your data is presented in the best light and enables those reading it to understand the value of your work.

How to structure your abstract:

Title: The title should accurately reflect the content of the abstract, ideally describing the scope of the investigation, study design and goal. The title should be easy to understand and avoid the use of jargon or abbreviations.

Authors: The list of authors should be restricted to those who carried out the study. The list of authors should be added in the order that the names should appear in the printed abstract should it be accepted. The institution, city and country of each author should be included. All authors listed should approve the abstract before it is submitted.

Introduction and Objectives: A brief summary of the current knowledge or state of the art in relation to the work you are presenting. Set out the aim of the study – ideally including a short statement of your hypothesis.

Methods: This should be a concise statement of the methods used including a brief outline of the study design, the context of the study and the type of data that was collected.

Results: The most important data in your study and the findings on which your conclusions are based. Include a table or figure only if this is required to show your results.

Conclusions: Brief outline explaining why these findings are important and describe their potential implications.

Challenging Cases in Respiratory and Challenging Cases in CF

The case: Please write a summary of the case with 3–4 anticipated discussion points (maximum 300 words).

Who? We particularly encourage respiratory trainees/fellows to submit cases, supported by a named consultant.

Successful applicants will be invited to present their case in the Challenging Respiratory and the Challenging CF Cases session, and their conference fees will be covered.

Encore abstracts may be submitted provided they have only been presented at only one meeting previously, e.g. ERS or ATS. The author should send an e-mail to info@paediatricrespiratory.com detailing when and where their abstract had been previously presented.

The Abstract Book
If your abstract is accepted for spoken or poster presentation at the Conference, it will be reproduced for the participants of the KJP Paediatric Respiratory Conference Abstract book.

Please note that abstracts will have a very limited amount of copy editing by the production team. This means that:

  • Your abstract will be reproduced as it is submitted on the abstract system
  • Abbreviations and definitions will be left as submitted so we encourage you to spell out abbreviations on first use unless they are very common
  • References will appear as they have been submitted (the full reference will not be added if this is incomplete)
  • The table or figure you submit will be reproduced as submitted so please ensure the legend/content is legible. All tables/figures are reproduced in black and white

Declarations of Interest:
If there are specific issues related to conflicts of interest that the authors wish to declare in connection with a particular abstract, please send an email outlining the details to info@paediatricrespiratory.com and we will retain this information on file with your abstract.

Confirmation of abstract submission:
Upon submission, a confirmation email will be sent to the submitters email address. If you do not receive the confirmation e-mail, please do not submit the abstract again. Instead, please contact info@paediatricrespiratory.com for advice.

Notification of acceptance:
Notifications of acceptance or rejection of the abstracts will be sent to the presenting author of the abstract.

All further communication, including notification letter, will be ONLY with the presenting author that has been indicated during the abstract submission.

 

Submission:
Abstracts can only be submitted for cases through the online platform.

SUBMISSION DEADLINE – 21 December 2025

YOU WILL BE CONTACTED VIA EMAIL REGARDING YOUR SUBMISSION DECISION IN JANUARY 2026.

Subscribe for future updates